Wolverine Asset Management’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-340,900
| Closed | -$3.2M | – | 2081 |
|
|
2020
Q3 | $3.2M | Buy |
340,900
+13,500
| +4% | +$128K | 0.03% | 306 |
|
|
2020
Q2 | $2.5M | Buy |
327,400
+92,200
| +39% | +$705K | 0.03% | 347 |
|
|
2020
Q1 | $1.45M | Sell |
235,200
-25,400
| -10% | -$224K | 0.02% | 417 |
|
|
2019
Q4 | $3.17M | Sell |
260,600
-164,200
| -39% | -$1.79M | 0.04% | 338 |
|
|
2019
Q3 | $4.91M | Buy |
424,800
+282,400
| +198% | +$2.97M | 0.06% | 228 |
|
|
2019
Q2 | $1.42M | Buy |
142,400
+115,300
| +425% | +$1.24M | 0.02% | 531 |
|
|
2019
Q1 | $349K | Buy |
+27,100
| New | +$404K | ﹤0.01% | 941 |
|
|
2018
Q4 | – | Sell |
-161,100
| Closed | -$3.22M | – | 1828 |
|
|
2018
Q3 | $3.22M | Sell |
161,100
-25,400
| -14% | -$578K | 0.04% | 405 |
|
|
2018
Q2 | $3.64M | Buy |
186,500
+56,500
| +43% | +$1.25M | 0.05% | 354 |
|
|
2018
Q1 | $2.62M | Buy |
+130,000
| New | +$2.2M | 0.03% | 430 |
|
|
2017
Q4 | – | Sell |
-92,900
| Closed | -$1.71M | – | 1666 |
|
|
2017
Q3 | $1.71M | Buy |
92,900
+82,900
| +829% | +$1.55M | 0.02% | 524 |
|
|
2017
Q2 | $184K | Sell |
10,000
-3,200
| -24% | -$63.4K | ﹤0.01% | 959 |
|
|
2017
Q1 | $297K | Sell |
13,200
-7,700
| -37% | -$184K | ﹤0.01% | 799 |
|
|
2016
Q4 | $727K | Buy |
20,900
+6,600
| +46% | +$197K | 0.01% | 602 |
|
|
2016
Q3 | $350K | Sell |
14,300
-6,300
| -31% | -$157K | 0.01% | 765 |
|
|
2016
Q2 | $492K | Buy |
20,600
+20,565
| +58,757% | +$471K | 0.01% | 702 |
|
|
2016
Q1 | $4K | Sell |
35
-15
| -30% | -$356 | ﹤0.01% | 1138 |
|
|
2015
Q4 | $1K | Buy |
+50
| New | +$1.61K | ﹤0.01% | 1650 |
|